tiprankstipranks
Trending News
More News >
Champions Oncology Inc (CSBR)
NASDAQ:CSBR
US Market
Advertisement

Champions Oncology (CSBR) Income Statement

Compare
140 Followers

Champions Oncology Income Statement

Last quarter (Q3 2025), Champions Oncology's total revenue was $17.04M, an increase of 41.77% from the same quarter last year. In Q3, Champions Oncology's net income was $4.50M. See Champions Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 50.16M$ 53.87M$ 49.11M$ 41.04M
Gross Profit
$ -28.39M$ 20.75M$ 24.34M$ 25.48M$ 19.57M
Operating Expenses
$ 24.00M$ 28.11M$ 28.79M$ 24.87M$ 19.23M
Depreciation and Amortization
$ 0.00$ 1.87M$ 3.20M$ 2.41M$ 1.58M
EBITDA
$ 4.55M$ -5.05M$ -2.07M$ 2.23M$ 366.00K
Operating Income
$ 4.55M$ -7.36M$ -4.45M$ 607.00K$ 338.00K
Other Income/Expenses
$ 73.00K$ 48.00K$ -11.00K$ -24.00K$ 71.00K
Pretax Income
$ 4.63M$ -7.31M$ -5.27M$ 583.00K$ 409.00K
Net Income
$ 4.70M$ -7.28M$ -5.33M$ 548.00K$ 362.00K
Per Share Metrics
Basic EPS
$ 0.34$ -0.54$ -0.39$ 0.04$ 0.03
Diluted EPS
$ 0.33$ -0.54$ -0.39$ 0.04$ 0.02
Weighted Average Shares Outstanding
13.66M 13.55M 13.54M 13.20M 13.14M
Weighted Average Shares Outstanding (Diluted)
14.27M 13.55M 13.54M 14.16M 14.57M
Currency in USD

Champions Oncology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis